Ivermectin: A Promising Ally in the Fight Against Colorectal Cancer (2025)

By Editorial Team -
Recent developments have sparked interest in the repurposing of ivermectin—a drug traditionally used as an antiparasitic—for its potential anticancer properties. In this article, we explore related evidence, mechanisms, and clinical insights.

Background and Rationale for Repurposing Ivermectin

Ivermectin has long been recognized for its safety profile and broad-spectrum antiparasitic activity. However, a growing body of research is now focusing on its potential antitumor effects. The drug’s established safety record makes it a compelling candidate for repurposing, particularly for conditions like colorectal cancer where new therapeutic options are in high demand.

  • Antiparasitic to Anticancer:
    Traditionally used to treat parasitic infections, ivermectin has now come under scrutiny for its ability to influence cancer cell biology. The OneDayMD articles collectively suggest that its mechanisms extend beyond mere antiparasitic activity, offering insights into its potential as an anticancer agent.

Evidence of Ivermectin’s Antitumor Effects in Colorectal Cancer

Early Preclinical and Clinical Insights

  • Antitumor Activity in Colorectal Models:
    An article from October 2021 presented preliminary studies demonstrating that ivermectin exhibits antitumor effects in colorectal cancer models. Laboratory investigations indicated that the drug might induce apoptosis (programmed cell death) and inhibit the proliferation of cancer cells, providing early evidence supporting its potential to interfere with tumor growth pathways in colorectal tissue (Ivermectin for Colorectal Antitumor, October 2021).

  • High-Dose Ivermectin and Tumor Shrinkage:
    A subsequent report from October 2023 discussed the effects of high-dose ivermectin, noting that increasing the dosage appeared to shrink tumor masses in certain contexts. This article emphasized that while standard doses might be insufficient, higher doses—administered under careful medical supervision—could enhance the drug’s antitumor activity. These findings highlight the potential of high-dose regimens, though they also stress the need for further research on safety and optimal dosing parameters (High-Dose Ivermectin Shrinks Cancer, October 2023).

Clinical Observations and Patient Outcomes

  • Surviving Colon Cancer with Ivermectin:
    The most recent update, published in December 2024, provided real-world clinical experiences where patients with advanced colon cancer received ivermectin as part of their treatment protocol. In several cases, patients experienced notable improvements, with the drug contributing to tumor reduction and overall disease stabilization. This narrative adds a layer of clinical validation to the laboratory findings, suggesting that ivermectin might offer supplementary treatment options for patients with limited alternatives (Surviving Colon Cancer with Ivermectin, December 2024).

Potential Mechanisms Underpinning Ivermectin’s Anticancer Effects

The articles converge on several hypotheses regarding how ivermectin might combat colorectal cancer:

  • Induction of Apoptosis:
    Ivermectin is believed to trigger apoptosis in cancer cells. By activating cellular pathways that lead to programmed cell death, the drug may help eliminate malignant cells from the colon.

  • Inhibition of Cell Proliferation:
    Research indicates that ivermectin can interfere with the signals that promote cell division. In doing so, it may slow down or halt the rapid proliferation of cancer cells—a hallmark of tumor growth.

  • Impact on the Tumor Microenvironment:
    There is evidence to suggest that ivermectin might alter the tumor microenvironment, making it less conducive to cancer progression. This includes possible effects on immune modulation and inflammation, both of which are critical factors in cancer development and metastasis.

Implications for Future Cancer Therapy

While the combined findings are encouraging, several important considerations remain:

  • Need for Rigorous Clinical Trials:
    Despite promising preclinical data and early clinical observations, robust clinical trials are essential to determine the efficacy, optimal dosing, and safety of ivermectin when used as an anticancer agent. The current evidence, although promising, primarily comes from observational studies and early-stage research.

  • Balancing Efficacy with Safety:
    High-dose ivermectin regimens appear to offer increased antitumor activity; however, the potential for side effects and toxicity must be carefully managed. Future studies will need to strike a balance between maximizing therapeutic benefits and minimizing risks.

  • A Complementary Approach:
    Rather than serving as a standalone cure, ivermectin may be best positioned as part of a multi-pronged treatment strategy. Its potential to enhance the effects of existing therapies or to provide benefits in otherwise treatment-resistant cases is a particularly exciting prospect.

Conclusion

The evolving story of ivermectin in the context of colorectal cancer treatment reflects a broader trend in medical research: the innovative repurposing of established drugs for new therapeutic applications. With early evidence suggesting that ivermectin can induce cancer cell death, inhibit tumor growth, and improve patient outcomes, it represents a promising adjunct in the battle against colorectal cancer. However, further rigorous studies and clinical trials are needed to fully establish its role and optimize its use in oncology.

As research continues to unfold, the medical community remains cautiously optimistic about the potential of ivermectin—a drug with a long history in infectious disease—now finding new purpose in the fight against cancer.

Sources:



Comments

Post a Comment

Labels

Show more

Archive

Show more

Popular posts from this blog

Ivermectin and Fenbendazole: Treating Turbo Cancer - Dr William Makis

By Editorial Team -
Image
Ivermectin Resources Recently, I have seen tremendous demand for some sort of initial guidance “WHERE TO START” with High Dose Ivermectin for CANCER. Editor's Note: Dr Makis proposes four distinct cancer protocols for using Ivermectin in cancer treatment, specifically for patients who have developed turbo cancer or aggressive cancers. These protocols, referred to as the “Dr. Makis Ivermectin Cancer Protocols,” are categorized based on dosage and the severity of the cancer. I have two articles and a Video that go into depth: June 10, 2024 - "15 minutes with Dr.Makis" - Episode 018: High Dose IVERMECTIN and CANCER 2024 - NEW STUDIES 2024 Baghli et al - Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: A Hybrid Orthomolecular Protocol First-in-the-World Ivermectin, Mebendazole and Fenbendazole Protocol in Cancer has been peer-reviewed and published on Sep.19, 2024. Co-authors include Dr Paul Marik and Dr William Makis. 2024 Fan et al  - Ivermectin Inhibi...
Read more

Fenbendazole Joe Tippens Protocol: A Step-by-Step Guide (2025)

By Editorial Team -
Image
If you have been diagnosed with cancer, or have a loved one that is suffering from cancer, chances are you have heard about the Joe Tippens Cancer Protocol. The Fenbendazole Cancer Protocol has been gaining rapid interest over the past years following some fenbendazole advanced cancer success stories . We have seen tremendous demand for some sort of guide on how to use fenbendazole for cancer as there is also tremendous confusion both from the healthcare and non-healthcare communities. Joe Tippens founded the protocol (1) after he was told a story about a scientist at Merck Animal Health that had been performing cancer research on mice. The research included injecting different types of cancers into different mice body parts. The scientists discovered, through trial and error, a product in their canine product line, fenbendazole, that was batting 1.000 in killing these different cancers in the mice. The scientist was later diagnosed with ...
Read more

Best Ivermectin Dosage for Humans with Cancer or Different Cancer Types (2025)

By Editorial Team -
Image
Introduction This article discusses dosage considerations and key factors regarding the use of ivermectin in cancer treatment. Commonly available information about ivermectin dosages is often inaccurate when applied to potential cancer-related uses.  Many sources cite standard dosages recommended by Merck for treating parasitic infections, rather than dosages studied specifically in the context of cancer research. The anti-parasitic dosage is not as effective for people looking for a dosage against cancer. Dosage will need to be adjusted according to cancer type and stage. Ivermectin dosage should be based on ivermectin cancer studies. Multiple factors are considered including studies including ivermectin for cancer, anecdotal studies and case series, the aggressiveness of the cancer type and the cancer stage. Cancer dosage estimation can be adjusted based on the time that a person has to beat cancer or its risk to the patient - this includes both the cancer type and whether the ca...
Read more

Fenbendazole Cancer Success Stories: 149 Case Reports Compilation (May 2025 Edition)

By Editorial Team -
Image
Table of Contents: Editor's Preface Introduction Fenbendazole Case Series Compilation (alphabetical) Breast Cancer Success Stories  (20 cases) Brain Cancer (including Glioblastoma) (3 cases) Bile Duct Cancer (Cholangiocarcinoma) Bladder Cancer Success Stories (7 cases) Cervical Cancer Colorectal Cancer  (20 cases) Esophageal and Stomach cancer (6 cases) Endometrial Cancer (4 cases) Gastric (Stomach) cancer (3 cases) Head and Neck Cancer (9 cases) Kidney Cancer Case Series (10 cases) Liver Cancer (2 cases) Lung Cancer (11 cases) Leukemia (2 cases) Lymphoma (6 cases) Melanoma (Skin Cancer) Multiple Myeloma (2 cases) Myelodysplastic Syndrome Oral Cancer Ovarian Cancer (2 cases) Pancreatic Cancer  (15 cases) Prostate Cancer  (18 cases) Sarcoma (2 cases) Skin Cancer (8 cases) Throat Canc...
Read more

Ivermectin, Fenbendazole and Mebendazole in Cancer: 2024 Peer-Reviewed Protocol in Cancer

By Editorial Team -
Image
We are pleased to announce that the first-of-its-kind protocol utilizing Ivermectin, Mebendazole, and Fenbendazole for cancer treatment has been peer-reviewed and officially published on September 19, 2024. Spearheaded by leading researchers like Dr. Ilyes Baghli, Dr. Pierrick Martinez, and the FLCCC’s Dr. Paul Marik, this groundbreaking protocol harnesses the untapped power of Ivermectin, Mebendazole, and Fenbendazole, known for their effectiveness against parasites. Now, these drugs are showing potential to battle cancer, marking the dawn of a new treatment evolution. This trio of repurposed drugs has been shown to disrupt the growth of cancer cells, particularly by targeting microtubules, the essential structures that allow cancer to multiply uncontrollably. What makes this protocol even more potent is the synergistic effect when these drugs are used together, creating a powerful new affordable weapon against cancer. According to oncologist Dr William Makis: “ This paper is the FI...
Read more

DMSO 101: Benefits, Uses, Dosage and Side Effects (2025)

By Editorial Team -
Image
DMSO is a medical abbreviation for DiMethyl SulfOxide. Modern medicine often sidelines "miracle" drugs that work too well. Despite decades of evidence showing that the naturally occurring chemical Dimethyl Sulfoxide (DMSO) is a remarkably safe and versatile treatment for a range of challenging conditions — such as strokes, head trauma, spinal cord injuries, dementia, and even Down Syndrome (63) — it has been largely overlooked. This sidelining is particularly remarkable as DMSO is also one of the most effective treatments for acute and chronic pain, musculoskeletal injuries, and chronic degenerative conditions (e.g., arthritis). DMSO, Nature’s Healer DMSO is a powerful, natural compound with several unique properties that make it an incredibly versatile healing agent: Rapid absorption —  When applied to the skin or ingested, DMSO quickly spreads throughout the body. ...
Read more

Fenbendazole vs Mebendazole for Cancer: What is the Difference?

By Editorial Team -
Image
What is Fenbendazole used for in humans?  Fenbendazole (also known as fenben) is a veterinary medication used to treat parasites and worms such as tapeworms, hookworms, roundworms, and whipworms, in animals. It is commonly used under brand names like Panacur C and Safe-Guard. If you have been diagnosed with cancer, or have a loved one that is suffering from cancer, chances are you have heard about the Joe Tippens Cancer Protocol. The Fenbendazole Cancer Protocol has been gaining rapid interest over the past years following some fenbendazole advanced cancer success stories. Joe Tippens founded the protocol after he was told a story about a scientist at Merck Animal Health that had been performing cancer research on mice. The research included injecting different types of cancers into different mice body parts. The scientists discovered, through trial and error, a product in their canine product line, fenbendazole, that was batting 1.000 in killing these di...
Read more

FENBENDAZOLE and CANCER: 15 Minutes with Dr. William Makis

By Editorial Team -
Image
Transcription (emphasis 2SG - 2nd Smartest Guy):  Hi, everyone. Welcome to another episode of 15 minutes with Dr. Makis, my new hard hitting medical podcast. This episode is about  fenbendazole  and cancer.  I will give you the most comprehensive review of the use of  fenbendazole  in cancer there is.   Fenbendazole  is an antiparasitic.  It is a dog dewormer, has been used It's been used as an antiparasitic since the 1960s,   and it has been shown to have extensive anti cancer activity.    Now, it's not FDA approved for use in humans. There is a version of it that is almost identical that is approved for use in humans by the FDA, and it's called mebendazole. (2SG: Mebendazole is BigPharma’s money grab whereby they removed a molecule from fenbendazole such that they could egregiously up-charge for a slightly inferior compound based on a bogus patent). I will do a separate video for mebe...
Read more

IVERMECTIN and CANCER: 15 Minutes with Dr. William Makis

By Editorial Team -
Image
Transcription (Video below): Hi, everyone. Welcome to another episode of 15 Minutes with Dr. Makis, my new hard-hitting medical podcast. It is now pretty well established that Pfizer and Moderna COVID-19 mRNA vaccines cause extremely aggressive cancers called turbocancer. They are gaslighting us about this. The medical establishment is burying their head in the sand. They're pretending that this phenomenon doesn't exist. 0:29 We've got a Wikipedia entry that quotes an oncologist in the States, Dr. David Gorski, who has received funding for his blog from child sex trafficker Jeffrey Epstein. He's written big articles claiming that this is a made-up phenomenon. But what you will find on social media is that thousands of people and their family 0:51 members are repo...
Read more

Fenbendazole for Humans: Dosage, Safety, Side Effects and Efficacy Examined (2025)

By Editorial Team -
Image
Fenbendazole is a broad spectrum anthelmintic used against gastrointestinal parasites including: giardia, roundworms, hookworms, whipworms, the tapeworm genus Taenia (but not effective against Dipylidium caninum, a common dog tapeworm), pinworms, aelurostrongylus, paragonimiasis, strongyles, and strongyloides that can be administered to sheep, cattle, horses, fish, dogs, cats, rabbits, most reptiles, freshwater shrimp tanks as planaria and hydra treatments, as well as seals. ( Wikipedia )  Fenbendazole, has garnered ⁤attention​ for its potential use ​in‍ humans.‍ The Fenbendazole Cancer Protocol gained rapid interest over the past years following some fenbendazole advanced cancer success stories . Joe Tippens founded the protocol  after he was told a story about a scientist at Merck Animal Health that had been performing cancer research on mice. The research included injecting different types of cancers into different mice body parts. The ...
Read more